Clin2
NCT07187011Possibly a fitNot yet recruiting

Study of PT150 for PTSD in veterans

PTSD - Post Traumatic Stress Disorder

Part of Injuries & trauma, Mental health clinical trials.

This study tests a new oral medication called PT150 to see if it helps reduce PTSD symptoms in Veterans. Participation involves taking the medication, regular check-ups, and questionnaires.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are a military Veteran or currently serving.
  • You are between 18 and 65 years old.
  • You have had PTSD for at least 3 months.
  • You are not severely dependent on alcohol or drugs (other than marijuana) in the last 3 months.
  • You are not currently planning suicide or have a history of suicide attempts.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06852469Recruiting· Phase 4
GABA test for PTSD in veterans

This trial uses a medication called lorazepam to study how GABA receptors work in veterans with PTSD. It aims to learn more about brain chemistry related to PTSD and how it might affect treatment.

San Diego, California
NCT05790239Recruiting· Phase 2
MDMA therapy sessions for veterans with PTSD

This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.

Los Angeles, California
NCT04452500Recruiting· Phase 2
Study drug for PTSD symptoms in Veterans

This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.

Tuscaloosa, Alabama
NCT07499440Recruiting· Phase 2
Testing a new medicine, HB-1, for PTSD

This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.

Deakin, Australian Capital Territory
NCT06989957Recruiting· Phase 1
Psilocybin and MDMA therapy for PTSD in veterans

This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.

Baltimore, Maryland
NCT06888128Recruiting· Phase 2
Psilocybin for PTSD in veterans

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Houston, Texas

Hear when a new PTSD - Post Traumatic Stress Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.